Novavax Inc. (NASDAQ:NVAX) is identified as one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. Citi initiated coverage on June 17 with a Sell rating and a $6 price target. The company focuses on developing new vaccines through innovative technologies, but faces challenges due to concentration in declining respiratory vaccines and uncertain healthcare policies.

Novavax Inc. (NVAX) is a biotech company specializing in recombinant vaccines. Despite its potential, some analysts believe other AI stocks offer better investment opportunities with less risk. For those interested in undervalued AI stocks, a free report on the best short-term AI stock is recommended. Check out 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now for more investment options.

Read more at Yahoo Finance: Citi Initiates Coverage of Novavax (NVAX) With a Sell Rating